Linked Data API

Show Search Form

Search Results

1007757
human indexable true more like this
published true more like this
registered interest false more like this
answer date remove filter
date less than 2018-11-15more like thismore than 2018-11-15
date tabled less than 2018-11-15more like thismore than 2018-11-15
ddp created less than 2018-11-15T19:09:32.180Zmore like thismore than 2018-11-15T19:09:32.180Z
answering body
Department of Health and Social Care more like this
question status Tabled more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
ddp modified
less than 2018-11-15T19:15:24.502Zmore like thismore than 2018-11-15T19:15:24.502Z
less than 2018-11-22T12:26:02.598Zmore like thismore than 2018-11-22T12:26:02.598Z
hansard heading Levetiracetam more like this
house id 1 more like this
identifier 191984 more like this
legislature
25259
pref label House of Commons more like this
parliament number 57 more like this
question first answered
remove filter
question text To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effect of the UK leaving the EU on the availability of Keppra for people with epilepsy. more like this
session
2017/19 more like this
session number 1 more like this
tabling member constituency Crewe and Nantwich more like this
tabling member printed
Laura Smith more like this
title House of Commons Tabled Parliamentary Question 2017/19 191984 more like this
type
WrittenParliamentaryQuestion
uin 191984 more like this
version 1 more like this
written parliamentary question type Ordinary more like this
answer answer
creator
4648
label Biography information for Laura Smith more like this
publisher
25259
pref label House of Commons more like this
tabling member
4648
label Biography information for Laura Smith more like this